Gigaxonin suppresses epithelial to mesenchymal transition (EMT) of human cancer through downregulation of Snail
Related Posts
Hao A, Yu RP, Kikuchi R, Sadrolashrafi K, Guo L, Yamamoto RK, Tolson H, Yee D, Bilimoria S, Pourali SP, Adler BL, Armstrong AW. Contact[...]
Biba U, Poppens MJ, Collier EK, Cheng K. Radiation therapy for a case of poikilodermatous plaques in an otherwise healthy young man: A case report.[...]
Chow F, Lamoureux F, Moriceau G. Editorial: Developing next-generation therapeutics to defeat mutation-driven cancer. Front Immunol. 2024 Sep 26;15:1487952. doi: 10.3389/fimmu.2024.1487952. PMID: 39391312; PMCID: PMC11464455.